Clinical trial
High-dose Intravenous Vitamin C for the Treatment of Severe Acute Pancreatitis
NCT06897384 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- High-dose Intravenous Vitamin C for the Treatment of Severe Acute Pancreatitis
- Lead sponsor
- Ruijin Hospital
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- March 1, 2025
- Completion date
- December 31, 2027
- Enrollment
- 388 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
severe acute pancreatitis